Luebke, A. M., Attarchi-Tehrani, A., Meiners, J., Hube-Magg, C., Lang, D. S., Kluth, M., . . . Höflmayer, D. (2019). Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers. Cancer Biol Med.
Chicago Style CitationLuebke, Andreas M., et al. "Loss of PSP94 Expression Is Associated With Early PSA Recurrence and Deteriorates Outcome of PTEN Deleted Prostate Cancers." Cancer Biol Med 2019.
Cita MLALuebke, Andreas M., et al. "Loss of PSP94 Expression Is Associated With Early PSA Recurrence and Deteriorates Outcome of PTEN Deleted Prostate Cancers." Cancer Biol Med 2019.
Atenció: Aquestes cites poden no estar 100% correctes.